- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 14, 2026 | 12.14M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 12.14M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 12.13M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 10.03M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 10.03M sh |
| Capex | Q2 2026 · Mar 31, 2026 | $1.17M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$1.93M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$361.77K |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $215.88K |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $159.56K |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $2.34M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $3.37M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $4.52M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | −$596.3K |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | −$206.12K |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $116.08K |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $640.76K |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $519.08K |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $640.76K |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $519.08K |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.08M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $4.78M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $2.98M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $5.04M |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.19 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$0.04 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.19 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | −$0.07 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $1.06M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $2.4M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $565.85K |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $1.11M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $73.17K |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $131.12K |
| Net Income | Q2 2026 · Mar 31, 2026 | −$1.03M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$2.33M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$1.3M |
| Net Income | Q2 2026 · Mar 31, 2025 | −$390.18K |
| Net Income | Q2 2026 · Mar 31, 2025 | −$712.38K |
| Net Income | Q2 2026 · Dec 31, 2024 | −$322.2K |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $271.26K |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $543.64K |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $232.29K |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $479.38K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $64.78K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $131.2K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $109.62K |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $217.17K |
| Revenue | Q2 2026 · Mar 31, 2026 | $336.04K |
| Revenue | Q2 2026 · Mar 31, 2026 | $674.85K |
| Revenue | Q2 2026 · Mar 31, 2025 | $341.91K |
| Revenue | Q2 2026 · Mar 31, 2025 | $696.55K |